New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents - Institut Pasteur Access content directly
Journal Articles Journal of Enzyme Inhibition and Medicinal Chemistry Year : 2019

New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents

Abstract

Starting from the analysis of the hypothetical binding mode of our previous furan-based hit (I), we successfully achieved our objective to replace the nitro moiety, leading to the disclosure of a new lead exhibiting a strong activity against MbtI. Our best candidate 1 h displayed a Ki of 8.8 µM and its antimycobacterial activity (MIC99 = 250 µM) is conceivably related to mycobactin biosynthesis inhibition. These results support the hypothesis that 5-phenylfuran-2-carboxylic derivatives are a promising class of MbtI inhibitors.
Fichier principal
Vignette du fichier
New insight into structure activity of furan based salicylate synthase MbtI inhibitors as potential antitubercular agents.pdf (2.88 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-03257047 , version 1 (10-06-2021)

Licence

Attribution - NonCommercial

Identifiers

Cite

Laurent Chiarelli, Matteo Mori, Giangiacomo Beretta, Arianna Gelain, Elena Pini, et al.. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents. Journal of Enzyme Inhibition and Medicinal Chemistry, 2019, 34 (1), pp.823-828. ⟨10.1080/14756366.2019.1589462⟩. ⟨pasteur-03257047⟩

Collections

PASTEUR CNRS
20 View
74 Download

Altmetric

Share

Gmail Facebook X LinkedIn More